TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients October 29, 2010
TCL Archive Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer March 28, 2003
TCL Archive Duke Vice Dean Cuffe Promises Complete, Independent Probe Of Work By Potti, Nevins. July 30, 2010
